Gene expression profiles in rat mesenteric lymph nodes upon supplementation with Conjugated Linoleic Acid during gestation and suckling

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Selga, Elisabet ^a   Pérez Cano, Francisco J ^a   Franch, Àngels ^a,b   Ramírez Santana, Carolina ^a,b   Rivero, Montserrat ^c   Ciudad, Carlos J ^a   Castellote, Cristina ^a,b   Noé, Véronique ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Scientific Park of Barcelona   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED LINOLEIC ACID; ACTIN; CONNECTIVE TISSUE GROWTH FACTOR; GALANIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MESSENGER RNA; SYNAPTOTAGMIN I; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACTIN GAMMA 2 GENE; ANIMAL EXPERIMENT; ARTICLE; CONNECTIVE TISSUE GROWTH FACTOR GENE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GALANIN GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2 GENE; MESENTERY LYMPH NODE; MUCOSAL IMMUNITY; NEWBORN; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; RAT; SMOOTH MUSCLE ALPHA ACTIN GENE; SUCKLING; SYNAPTOTAGMIN 1 GENE; TISSUE INHIBITOR OF METALLOPROTEINASE 1 GENE; ANIMAL; GENE REGULATORY NETWORK; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LYMPH NODE; MESENTERY; METABOLISM; WISTAR RAT;

ANIMALIA; RATTUS;

ACTINS; ANIMALS; ANIMALS, NEWBORN; ANIMALS, SUCKLING; CONNECTIVE TISSUE GROWTH FACTOR; DIETARY SUPPLEMENTS; FEMALE; GALANIN; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GRB2 ADAPTOR PROTEIN; LINOLEIC ACIDS, CONJUGATED; LYMPH NODES; MESENTERY; PREGNANCY; RATS; RATS, WISTAR; RNA, MESSENGER; SYNAPTOTAGMIN I; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 79953800181     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-182     Document Type: Article

References (67)

1. Sanderson IR, Naik S. Dietary regulation of intestinal gene expression. Annu Rev Nutr 2000, 20:311-338. 10.1146/annurev.nutr.20.1.311, 10940337.
2. Wallace FA, Miles EA, Evans C, Stock TE, Yaqoob P, Calder PC. Dietary fatty acids influence the production of Th1- but not Th2-type cytokines. J Leukoc Biol 2001, 69:449-457.
3. Calder PC, Field CJ. Fatty acids, inflamation and immunity. Nutrition and Immune Function 2002, 57-92. Southhampton (UK): CAB International, Calder PC, Field CJ, Gill HS.
4. Field CJ, Clandinin MT, Van Aerde JE. Polyunsaturated fatty acids and T-cell function: implications for the neonate. Lipids 2001, 36:1025-1032. 10.1007/s11745-001-0813-6, 11724454.
5. Mcguire MK, Park Y, Behre RA, Harrison LY, Shultz TD, Mcguire MA. Conjugated linoleic acid concentrations of human milk and infant formula. Nutr Res 1997, 17:1277-1283.
6. Jensen RG, Lammi-Keefe C. The anticarcinogenic conjugated fatty acid c9, t11-c18:2, or rumenic acid, in human milk: amounts and effects. Adv Exp Med Biol 2001, 501:153-156.
7. Luna P, Juarez M, de la Fuente MA. Fatty acid and conjugated linoleic acid isomer profiles in human milk fat. Eur J Lipid Sci Technol 2007, 109:1160-1166.
8. Chin SF, Storkson JM, Albright KJ, Cook ME, Pariza MW. Conjugated linoleic acid is a growth factor for rats as shown by enhanced weight gain and improved feed efficiency. J Nutr 1994, 124:2344-2349.
9. Pariza MW, Park Y, Cook ME. Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc Soc Exp Biol Med 2000, 223:8-13. 10.1046/j.1525-1373.2000.22302.x, 10632956.
10. Hayashi AA, de Medeiros SR, Carvalho MH, Lanna DP. Conjugated linoleic acid (CLA) effects on pups growth, milk composition and lipogenic enzymes in lactating rats. J Dairy Res 2007, 74:160-166. 10.1017/S002202990600224X, 17291385.
11. Visonneau S, Cesano A, Tepper SA, Scimeca JA, Santoli D, Kritchevsky D. Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID mice. Anticancer Res 1997, 17:969-973.
12. Ip MM, Masso-Welch PA, Shoemaker SF, Shea-Eaton WK, Ip C. Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res 1999, 250:22-34. 10.1006/excr.1999.4499, 10388518.
13. Kelley NS, Hubbard NE, Erickson KL. Conjugated linoleic acid isomers and cancer. J Nutr 2007, 137:2599-2607.
14. Perez-Cano FJ, Ramirez-Santana C, Molero-Luis M, Castell M, Rivero M, Castellote C, Franch A. Mucosal IgA increase in rats by continuous CLA feeding during suckling and early infancy. J Lipid Res 2009, 50:467-476. 10.1194/jlr.M800356-JLR200, 18824724.
15. Ramirez-Santana C, Perez-Cano FJ, Castellote C, Castell M, Rivero M, Rodriguez-Palmero M, Franch A. Higher immunoglobulin production in conjugated linoleic acid-SUPPLemented rats during gestation and suckling. Br J Nutr 2009, 102:858-868. 10.1017/S0007114509301592, 19338709.
16. Ramírez-Santana C, Castellote C, Castell M, Moltó-Puigmartí C, Rivero M, Pérez-Cano FJ, Franch A. Enhancement of antibody synthesis in rats by feeding cis-9,trans-11 conjugated linoleic acid during early life. J Nutr Biochem 2010 , 22:495-501.
17. Ramirez-Santana C, Castellote C, Castell M, Rivero M, Rodriguez-Palmero M, Franch A, Perez-Cano FJ. Long-term feeding of the cis-9,trans-11 isomer of conjugated linoleic acid reinforces the specific immune response in rats. J Nutr 2009, 139:76-81.
18. Kaput J. Nutrigenomics research for personalized nutrition and medicine. Curr Opin Biotechnol 2008, 19:110-120. 10.1016/j.copbio.2008.02.005, 18387295.
19. Hubner N, Wallace CA, Zimdahl H, Petretto E, Schulz H, Maciver F, Mueller M, Hummel O, Monti J, Zidek V, et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet 2005, 37:243-253. 10.1038/ng1522, 15711544.
20. Mutch DM, Grigorov M, Berger A, Fay LB, Roberts MA, Watkins SM, Williamson G, German JB. An integrative metabolism approach identifies stearoyl-CoA desaturase as a target for an arachidonate-enriched diet. FASEB J 2005, 19:599-601. 10.1096/fj.05-3911rev, 15670975.
21. Berger A, Mutch DM, German JB, Roberts MA. Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Lipids Health Dis 2002, 1:2. 10.1186/1476-511X-1-2, 139963, 12617750.
22. Anderle P, Farmer P, Berger A, Roberts MA. Nutrigenomic approach to understanding the mechanisms by which dietary long-chain fatty acids induce gene signals and control mechanisms involved in carcinogenesis. Nutrition 2004, 20:103-108. 10.1016/j.nut.2003.09.018, 14698023.
23. Gene Expression Omnibus. , http://www.ncbi.nlm.nih.gov/geo
24. Rachfal AW, Brigstock DR. Structural and functional properties of CCN proteins. Vitam Horm 2005, 70:69-103. 10.1016/S0083-6729(05)70003-0, 15727802.
25. Cicha I, Goppelt-Struebe M. Connective tissue growth factor: context-dependent functions and mechanisms of regulation. Biofactors 2009, 35:200-208. 10.1002/biof.30, 19449449.
26. Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 2009, 41:771-783. 10.1016/j.biocel.2008.07.025, 2668982, 18775791.
27. Welgus HG, Stricklin GP. Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem 1983, 258:12259-12264.
28. Nuttall RK, Sampieri CL, Pennington CJ, Gill SE, Schultz GA, Edwards DR. Expression analysis of the entire MMP and TIMP gene families during mouse tissue development. FEBS Lett 2004, 563:129-134. 10.1016/S0014-5793(04)00281-9, 15063736.
29. Stetler-Stevenson WG. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal 2008, 1:re6. 10.1126/scisignal.127re6, 2493614, 18612141.
30. Hubbard NE, Lim D, Erickson KL. Conjugated linoleic acid alters matrix metalloproteinases of metastatic mouse mammary tumor cells. J Nutr 2007, 137:1423-1429.
31. Ringseis R, Schulz N, Saal D, Eder K. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages. J Nutr Biochem 2008, 19:594-603. 10.1016/j.jnutbio.2007.08.003, 18155510.
32. McCown TJ. Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity. Neurotherapeutics 2009, 6:307-311. 10.1016/j.nurt.2009.01.004, 19332324.
33. Genton L, Kudsk KA. Interactions between the enteric nervous system and the immune system: role of neuropeptides and nutrition. Am J Surg 2003, 186:253-258. 10.1016/S0002-9610(03)00210-1, 12946828.
34. Pascual DW, Stanisz AM, Bienenstock J, Bost KL. Neural intervention in mucosal immunity. Mucosal Immunology 1999, 631-642. San Diego: Academic Press, Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, 2.
35. Gabrilovac J, Marotti T. Gender-related differences in murine T- and B-lymphocyte proliferative ability in response to in vivo [Met(5)]enkephalin administration. Eur J Pharmacol 2000, 392:101-108. 10.1016/S0014-2999(00)00118-7, 10748278.
36. Del Rio M, Hernanz A, de la Fuente M. Bombesin, gastrin-releasing peptide, and neuromedin C modulate murine lymphocyte proliferation through adherent accessory cells and activate protein kinase C. Peptides 1994, 15:15-22. 10.1016/0196-9781(94)90164-3, 8015972.
37. Sugimoto T, Seki N, Shimizu S, Kikkawa N, Tsukada J, Shimada H, Sasaki K, Hanazawa T, Okamoto Y, Hata A. The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma. Genes Chromosomes Cancer 2009, 48:132-142. 10.1002/gcc.20626, 18973137.
38. Stanisz AM, Befus D, Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 1986, 136:152-156.
39. Tucker WC, Chapman ER. Role of synaptotagmin in Ca2+-triggered exocytosis. Biochem J 2002, 366:1-13. 1222778, 12047220.
40. Chakrabarti S, Kobayashi KS, Flavell RA, Marks CB, Miyake K, Liston DR, Fowler KT, Gorelick FS, Andrews NW. Impaired membrane resealing and autoimmune myositis in synaptotagmin VII-deficient mice. J Cell Biol 2003, 162:543-549. 10.1083/jcb.200305131, 2173791, 12925704.
41. Brose N, Petrenko AG, Sudhof TC, Jahn R. Synaptotagmin: a calcium sensor on the synaptic vesicle surface. Science 1992, 256:1021-1025. 10.1126/science.1589771, 1589771.
42. McNeil PL, Steinhardt RA. Loss, restoration, and maintenance of plasma membrane integrity. J Cell Biol 1997, 137:1-4. 10.1083/jcb.137.1.1, 2139853, 9105031.
43. Colvin RA, Means TK, Diefenbach TJ, Moita LF, Friday RP, Sever S, Campanella GS, Abrazinski T, Manice LA, Moita C, et al. Synaptotagmin-mediated vesicle fusion regulates cell migration. Nat Immunol 11:495-502. 10.1038/ni.1878, 20473299.
44. Lang J, Fukuda M, Zhang H, Mikoshiba K, Wollheim CB. The first C2 domain of synaptotagmin is required for exocytosis of insulin from pancreatic beta-cells: action of synaptotagmin at low micromolar calcium. EMBO J 1997, 16:5837-5846. 10.1093/emboj/16.19.5837, 1170215, 9312042.
45. Gao Z, Reavey-Cantwell J, Young RA, Jegier P, Wolf BA. Synaptotagmin III/VII isoforms mediate Ca2+-induced insulin secretion in pancreatic islet beta -cells. J Biol Chem 2000, 275:36079-36085. 10.1074/jbc.M004284200, 10938083.
46. Mouta Carreira C, LaVallee TM, Tarantini F, Jackson A, Lathrop JT, Hampton B, Burgess WH, Maciag T. S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro. J Biol Chem 1998, 273:22224-22231. 10.1074/jbc.273.35.22224, 9712836.
47. Textor B, Licht AH, Tuckermann JP, Jessberger R, Razin E, Angel P, Schorpp-Kistner M, Hartenstein B. JunB is required for IgE-mediated degranulation and cytokine release of mast cells. J Immunol 2007, 179:6873-6880.
48. Sudhof TC. Synaptotagmins: why so many?. J Biol Chem 2002, 277:7629-7632. 10.1074/jbc.R100052200, 11739399.
49. Reist NE, Buchanan J, Li J, DiAntonio A, Buxton EM, Schwarz TL. Morphologically docked synaptic vesicles are reduced in synaptotagmin mutants of Drosophila. J Neurosci 1998, 18:7662-7673.
50. Geppert M, Goda Y, Hammer RE, Li C, Rosahl TW, Stevens CF, Sudhof TC. Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell 1994, 79:717-727. 10.1016/0092-8674(94)90556-8, 7954835.
51. Rastaldi MP, Armelloni S, Berra S, Calvaresi N, Corbelli A, Giardino LA, Li M, Wang GQ, Fornasieri A, Villa A, Heikkila E, Soliymani R, Boucherot A, Cohen CD, Kretzler M, Nitsche A, Ripamonti M, Malgaroli A, Pesaresi M, Forloni GL, Schlöndorff D, Holthofer H, D'Amico G. Glomerular podocytes contain neuron-like functional synaptic vesicles. FASEB J 2006, 20:976-978. 10.1096/fj.05-4962fje, 16585060.
52. Guillen N, Navarro MA, Arnal C, Noone E, Arbones-Mainar JM, Acin S, Surra JC, Muniesa P, Roche HM, Osada J. Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver. Physiol Genomics 2009, 37:187-198. 10.1152/physiolgenomics.90339.2008, 2685506, 19258494.
53. Koh TW, Bellen HJ. Synaptotagmin I, a Ca2+ sensor for neurotransmitter release. Trends Neurosci 2003, 26:413-422. 10.1016/S0166-2236(03)00195-4, 12900172.
54. Littleton JT, Bai J, Vyas B, Desai R, Baltus AE, Garment MB, Carlson SD, Ganetzky B, Chapman ER. synaptotagmin mutants reveal essential functions for the C2B domain in Ca2+-triggered fusion and recycling of synaptic vesicles in vivo. J Neurosci 2001, 21:1421-1433.
55. Hoyle CH, Burnstock G. Galanin-like immunoreactivity in enteric neurons of the human colon. J Anat 1989, 166:23-33. 1256736, 2482838.
56. Wickramarachchi DC, Theofilopoulos AN, Kono DH. Immune pathology associated with altered actin cytoskeleton regulation. Autoimmunity 43:64-75. 10.3109/08916930903374634, 20001423.
57. Janmey PA. The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol Rev 1998, 78:763-781.
58. Chesarone MA, Goode BL. Actin nucleation and elongation factors: mechanisms and interplay. Curr Opin Cell Biol 2009, 21:28-37. 10.1016/j.ceb.2008.12.001, 2671392, 19168341.
59. Goldberg MT, Han YP, Yan C, Shaw MC, Garner WL. TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing. J Invest Dermatol 2007, 127:2645-2655. 10.1038/sj.jid.5700890, 2366884, 17554369.
60. Liu Y, Sinha S, Owens G. A transforming growth factor-beta control element required for SM alpha-actin expression in vivo also partially mediates GKLF-dependent transcriptional repression. J Biol Chem 2003, 278:48004-48011. 10.1074/jbc.M301902200, 12970361.
61. Casey TM, Eneman J, Crocker A, White J, Tessitore J, Stanley M, Harlow S, Bunn JY, Weaver D, Muss H, Plaut K. Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study. Breast Cancer Res Treat 2008, 110:39-49. 10.1007/s10549-007-9684-7, 17674196.
62. Fagarasan S, Kawamoto S, Kanagawa O, Suzuki K. Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol 2010, 28:243-273. 10.1146/annurev-immunol-030409-101314, 20192805.
63. Neusser MA, Kraus AK, Regele H, Cohen CD, Fehr T, Kerjaschki D, Wuthrich RP, Penfold ME, Schall T, Segerer S. The chemokine receptor CXCR7 is expressed on lymphatic endothelial cells during renal allograft rejection. Kidney Int 2010, 77:801-808. 10.1038/ki.2010.6, 20164826.
64. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
65. Perez-Cano FJ, Marin-Gallen S, Castell M, Rodriguez-Palmero M, Rivero M, Franch A, Castellote C. Bovine whey protein concentrate SUPPLementation modulates maturation of immune system in suckling rats. Br J Nutr 2007, 98(SUPPL 1):S80-84.
66. Bader GD, Donaldson I, Wolting C, Ouellette BF, Pawson T, Hogue CW. BIND--The Biomolecular Interaction Network Database. Nucleic Acids Res 2001, 29:242-245. 10.1093/nar/29.1.242, 29820, 11125103.
67. Zanzoni A, Montecchi-Palazzi L, Quondam M, Ausiello G, Helmer-Citterich M, Cesareni G. MINT: a Molecular INTeraction database. FEBS Lett 2002, 513:135-140. 10.1016/S0014-5793(01)03293-8, 11911893.